Lower the risk of metabolic syndrome with Omega-7
Learn how Omega 7 can enhance cardiovascular wellness and bring metabolic health
New research reveals that supplementation with omega-7 fatty acids, particularly palmitoleic acid, may significantly improve markers associated with metabolic syndrome.
Omega-7, a monounsaturated fatty acid abundant in sea buckthorn berries and macadamia nuts, has gained attention for its potential to improve metabolic health, reduce chronic inflammation, and support cardiovascular wellness.
Metabolic syndrome refers to a cluster of health conditions—including abdominal obesity, insulin resistance, elevated blood sugar, high blood pressure, and unhealthy cholesterol levels—that significantly increase the risk of type 2 diabetes, cardiovascular disease, and certain cancers.
Clinical trials highlight metabolic health benefits:
Emerging human clinical trials demonstrate that daily omega-7 supplementation can substantially reduce several critical metabolic and inflammatory biomarkers. Recent clinical data documented a 44% reduction inC-Reactive Protein, an important inflammatory marker linked to cardio vascular risk, and a 26% decrease in TNF-alpha, another key inflammatory cytokine involved in chronic inflammation.
Furthermore, omega-7 supplementation positively influenced lipid metabolism, leading to a 15% reduction in triglycerides and an 8%decrease in low-density lipoprotein cholesterol. Simultaneously, beneficial high-density lipoprotein cholesterol levels increased significantly by 15%.These results underscore omega-7’s potential as a nutraceutical solution to manage multiple factors involved in metabolic syndrome.
“Omega-7 fatty acids represent a promising nutritional strategy for managing metabolic syndrome and associated cardiovascular risks,”noted researchers, highlighting omega-7’s distinct ability to address inflammation, lipid imbalances, and insulin sensitivity.”
CardiOmegia™ delivers premium omega-7 support
Responding to growing consumer demand for effective, science-backed ingredients, Puredia introduces CardiOmegia™, a premium nutraceutical ingredient standardized to deliver 45% omega-7 in its natural triglyceride form. CardiOmegia™ is sustainably extracted from the fruit of the ancient sea buckthorn plant, grown exclusively on the pristine Tibetan Plateau, using advanced supercritical CO₂ extraction technology.
Sustainably produced, ethically sourced ingredients
CardiOmegia™ ingredients are organic, non-GMO, halal, kosher, NSF GMP, and BRC certified. Sustainably grown and responsibly produced, CardiOmegia™ aligns ideally with consumer demand for transparency, high-quality sourcing, and ethical manufacturing practices.
Discover how CardiOmegia™ can enhance your nutraceutical formulations and bring metabolic health benefits to your consumers—contact the Puredia team today.
Featured Ingredient
CardiOmegia™, Highest Omega 7 in Natural Triglyeride Form
100% Plant-Based
Organic-Certified
No Additive
Available in oil & powder form
TRI-CAP™ Microencapsulated
Sustainably & Responsibly Made
These ingredients are certified with:
Reference
Virgolici B. et al. (2013), ISRN Oxidative Medicine, 2013:164941.
Chan E. et al. (2024), Journal of Functional Foods, 112:105973.
Bernstein A. et al. (2014), Journal of Clinical Lipidology, 8(6):612-617.